As drug pricing strategies continue to evolve, Express Scripts (NASDAQ: ESRX) is keeping clients ahead of the game. Today, the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE